How Should Randomized Controlled Trials in Epithelial Ovarian Cancer Be Interpreted?

Inge Peters,Andrea Rosati,Giovanni Scambia,Anna Fagotti

International journal of gynecological cancer（2022）

引用 0|浏览0

暂无评分

摘要

In their recent article in the New England Journal of Medicine , Harter and colleagues reported on the beneficial survival outcomes of secondary cytoreductive surgery in combination with chemotherapy compared with chemotherapy alone in patients with recurrent epithelial ovarian cancer (Desktop III

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要